ICON

PRA International is a prominent contract research organization that offers outsourced clinical development and data solution services to the pharmaceutical and biotechnology industries worldwide. The company operates through two primary segments: Clinical Research and Data Solutions. The Clinical Research segment provides comprehensive services including clinical trial management, regulatory affairs, and therapeutic expertise, along with early development services for Phase I and IIa studies. The Data Solutions segment focuses on delivering data analytics, consulting, and technology-enabled solutions to the life sciences market. With over 10,000 employees across more than 80 countries, PRA is involved in conducting clinical trials for various therapeutic areas, including oncology and immunology. The organization plays a significant role in drug development, having contributed to the regulatory approval of numerous marketed drugs. PRA International, founded in 1976 and headquartered in Raleigh, North Carolina, is committed to excellence and innovation in its partnerships with clients.

MedPass is the leading European Medical Device CRO and Regulatory and Reimbursement Consultancy. MedPass has helped to advance the development of breakthrough medical device technologies by offering a broad range of strategic and operational services tailored to meet the needs of clients around the globe.

Accellacare specializes in clinical trials designed to assess the safety and effectiveness of new medications. The organization prioritizes patient care and provides a supportive environment for participants. Accellacare was previously known as MeDiNova Research.

MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMD’s assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.

Mapi is the leading Patient-Centered Research company serving academia, life science researchers, and the pharmaceutical industry for over 40 years. Mapi’s commitment to patient-focused research is demonstrated not only by our expertise and nearly four decades of service but also through our direct contribution back to the industry. Mapi is among only a handful of global organizations that is capable of engaging with a patients’ complete ecosystem, their HCPs, Patient Communities, payers, and even regulators. And only Mapi has the unique history to make us the most experienced at interacting with all of them. Mapi was founded in 1974 and was focused on the patient from the very beginning. With our Real-World Evidence and post-approval research services, consulting expertise, and publications to our not-for-profit entity, Mapi has been the leading industry driver toward patient-centered research for nearly four decades.

ClinicalRM is a full-service Contract Research Organization specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. The organization helps customers get their products to market faster with a wide array of research, regulatory and sponsor services within the U.S. and around the globe. From international partnerships and affiliations to government relations and local alliances, ClinicalRM delivers a synergy in the global market with projects spanning the government, academic and commercial marketplaces. The company has a distinct ability to provide boots-on-the-ground and rapid response efforts to global health crises.

PMG Research, Inc. is an integrated network of clinical research facilities in the United States. PMG has been conducting clinical trials since 1979. Our progressive organization is comprised of a team of highly effective professionals and a network of specially-designed sites. Our goal is to provide exceptional services to our sponsors and participants. PMG has conducted over 7,700 research studies for hundreds of pharmaceutical sponsors and CROs. We have extensive experience conducting all phases of trials across a comprehensive list of conditions.

MediMedia Managed Markets provides you with the best strategic expertise available in the industry. Their large staff of managed markets strategists, researchers, MDs, PharmDs, and MPHs, all proven experts in the field, will help.

Aptiv Solutions, Inc. operates as a clinical research organization that offers clinical trial services. The company also provides adaptive trial design, simulation, and execution; early phase development consulting; pre clinical development; and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It also offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. Aptiv Solutions, Inc. was formerly known as Averion International Corp. and changed its name to Aptiv Solutions, Inc. in February 2011. The company was founded in 1983 and is based in Reston, Virginia with an office in Durham, North Carolina.

Cross Country Healthcare is a provider of staffing and workforce solutions for the healthcare sector. It offers services including temporary, permanent, and locum tenens placements, along with advisory services to meet labor-related challenges.

PriceSpective is a value strategy consultancy that defines, drives, and captures value for pharmaceutical and biotechnology clients in today's complex healthcare environment. The company delivers expert guidance in integrated global pricing, reimbursement and market access strategy with its depth of experience and actively engaged senior leadership. PriceSpective is headquartered in Philadelphia with offices in London, Los Angeles, San Diego, Raleigh and Boston.

Beijing Wits Medical Consulting Company was founded in 1997. The company provides services to global and local pharmaceutical, medical device and biotechnology companies focusing on Phase I to IV Clinical studies. Beijing Wits currently has more than 100 employees, operating from 6 offices in China.

Firecrest Clinical Ltd provides site performance management solution that is used by pharma companies to improve compliance, consistency.

Oxford Outcomes provides specialist services in the fields of patient reported outcomes (PRO), health economics, epidemiology and translation and linguistic validation.

Timaq Medical Imaging is a Swiss based provider of advanced imaging services to pharmaceutical and biotech firms.

Veeda Laboratories Ltd is a specialist provider of biomarker laboratory services to global pharmaceutical and biotechnology industries.

Prevalere Life Sciences, Inc is a contract research organization, provides consulting and GLP/cGMP compliant analytical testing services.

Barton & Polansky Associates, Inc is specialises in clinical research services for immuno-suppressant drugs.

UCT (U.S.), Inc provides central laboratory services for clinical trials to the pharmaceutical and biotechnology industries.

Pacific Research Associates, Inc is specialising in data management statistical analysis and medical and regulatory consulting.